HMGIC (high mobility group protein isoform I-C) by Pedeutour, F









Atlas Genet Cytogenet Oncol Haematol. 2000; 4(2)  
 
64 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
OPEN ACCESS JOURNAL AT INIST-CNRS 
HMGIC (High mobility group protein isoform I-C) 
Florence Pedeutour 
UF Recherche Clinique 952, Laboratoire de Génétique, Université de Nice-Sophia Antipolis, CHU de Nice, 
06202 Nice, France (FP) 
 
Published in Atlas Database: May 2000 
Online updated version : http://AtlasGeneticsOncology.org/Genes/HMGICID82.html 
DOI: 10.4267/2042/37615 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2000 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Identity 
HGNC (Hugo): HMGIC 
Location: 12q15 
Local order: Telomeric to CDK4, centromeric to 
MDM2. 
 
Probe(s) - Courtesy Mariano Rocchi. 
DNA/RNA 
Description 
5 exons, spans approximately 160 kb; the size of intron 
3 is 140 kb. 
Transcription 
RNA: 4.1 kb. 
Protein 
Description 
109 amino acids; three DNA binding domains (AT 
hooks) linked to the carboxy-terminal acidic domain 
that does not activate transcription. 
Expression 
Fetal tissues: expression in various tissues, prominent 
in kidney, liver and uterus; adult tissues: no exprssion 
except in lung and kidney; tumors: expression in 

















Architectural factor, non histone, preferential binding 
to AT rich sequences in the minor groove of DNA 
helix; the precise function remains to be elucidate; 
probable role in regulation of cell proliferation. 
 
Homology 
Member of the HMGI protein family. 
Mutations 
Germinal 
Deletion of HMGIC in mutant mice or transgenic 
'knock out' mice for the first two exons of HMGIC 
have the 'pigmy' phenotype: low birth weight, 
craniofacial defects, adipocyte hypoplasia adult body 
weight about 40% of normal. 
Implicated in 








Various rearrangements involving 12q15 
(translocations, inversions, deletions...); reciprocal 
translocations involve 12q15 with different partners 
such as chromosomes 1, 3, 7, 10, 11, 13, 15, 17, 21, X; 
the most frequent anomaly is t(3;12)(q27-28;q15); 
cryptic rearrangements, such as paracentric inversions 
not detectable by conventional cytogenetics but 
detectable by FISH, have been described. 
Hybrid/Mutated gene 
For t(3;12): HMGIC-LPP (LPP: lipoma prefered 
partner; 3q27-28); a gene located in 13q, LHFP (lipoma 
HMGIC fusion partner) was found to be fused with 
HMGIC in one case of lipoma. 
Abnormal protein 
HMGIC-LPP; the three AT hook domains at the 
aminoterminal of HMGIC are fused to the LIM domain  
of LPP; another fusion protein due to the fusion of 
HMGIC with a putative gene located at 15q24 
predicted to encode a protein with a serine/threonine-
rich domain has also been described. 
Oncogenesis 
The relevance of the exact role LPP in the HMGIC-
LPP fusion is not established yet; the truncation of 
HMGIC may have a role in the tumorigenesis. 
Uterine leiomyoma (uterine fibroids) 
Disease 




Approximately 40% of uterine leiomyomas have 
structural chromosomal rearrangements, about 10% of 
which involve 12q15 (translocations, inversions, 
deletions...); the most frequent anomaly is 
t(12;14)(q15;q23-24). 
Hybrid/Mutated gene 
In a majority of cases, there is no fusion gene: th 
breakpoint is located 10 kb up to 100 kb 5' to HMGIC; 
the recombinational repair gene RAD51B is a 
candidate to be the partner gene of HMGIC in t(12;14); 
in one case with paracentric inversion, HMGIC exon 3 
was fused to ALDH2 exon 13 (12q24.1); in one case 
(no cytogenetic analysis) HMGIC exon 3 was fused to 
COX6C 3' UTR (8q22-23); in one case, with 
apparently normal karyotype, exon 3 of HMGIC was 




HMGIC-ALDH2: ALDH2 contribution was only 10 
amino acids. 
Oncogenesis 
HMGIC-ALDH2: it is suggested that the truncation of 
HMGIC, rather than fusion may be responsible for 
tumorigenesis; the 3' untranslated region may stabilize 
the HMGIC messenger RNA. 
Pleomorphic adenoma of the salivary gland (or 
mixed salivary gland tumor) 
Disease 














Approximately 12% of pleomorphic adenomas of 
salivary glands show abnormalities involving HMGIC 
in 12q15; the most frequent aberration is 
t(9;12)(p24.1;q15). 
Hybrid/Mutated gene 
In t(9;12): HMGIC-NFIB fusion; another type of fusion 
HMGIC-FHIT (3p14.2) has also been described. 
Pulmonary chondroid hamartoma of the lung 
Disease 




Various rearrangements involving 12q15 leading to 
HMGIC dysregulation; cryptic rearrangements such as 
paracentric inversions not detectable by conventional 
cytogenetics but detectable by FISH have been 
described. 
Hybrid/Mutated gene 
In two cases with apparently normal karyotypes, exon 3 
of HMGIC was fused to retrotransposon-like sequences 
RTVLH 3' LTRs; in five cases with t(3;12)(q27;q15) 








Various rearrangements involving 12q15 leading to 
HMGIC dysregulation; cryptic rearrangements such as 
paracentric inversions not detectable by conventional 
cytogenetics but detectable by FISH have been 
described; in one case, HMGIC was amplified and 
overexpressed. 
Myofibroblastic inflammatory tumor 
Disease 




In one case, a complex rearrangement involving 
chromosomes 12 (in 12q15), 4 and 21 was described. 
Hybrid/Mutated gene 
An aberrant transcript was produced by the fusion of 
HMGIC exon 3 to an ectopic sequence originating from 
the third intron of HMGIC. 
Malignant tumors as follows: 
Well-differentiated liposarcoma 
Disease 
Malignant adipocyte tumor; peripheral or 
retroperitoneal location. 
Prognosis 
Rather good; borderline malignancy; locally 
aggressive, rarely metastasizes. 
Cytogenetics 
Supernumerary ring or giant marker chromosomes 
containing 12q14-15 amplification (surrounding 
MDM2); HMGIC is frequently amplified together with 
MDM2; in two cases, a rearrangement of HMGIC, in 
addition to amplification has been described. 
Hybrid/Mutated gene 
In one case an ectopic sequence from unknown origin 





In one osteosarcoma cell line (OsA-Cl) the three DNA 
binding domains of HMGIC fused to the keratan sulfate 
protein glycan gene LUM (12q22-23); LUM was fused 
out of frame, and only 3 amino acids were fused to 
HMGIC; in addition, the rearranged gene was 
amplified. 
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